NORGES BANK - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORGES BANK ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$15,287,199
+5.4%
428,5730.0%0.00%0.0%
Q3 2022$14,507,196
+17.0%
428,5730.0%0.00%
+33.3%
Q2 2022$12,394,331
-19.3%
428,573
-9.8%
0.00%0.0%
Q1 2022$15,356,331
+6.3%
475,134
-4.1%
0.00%0.0%
Q4 2021$14,443,000
+22.9%
495,313
+12.4%
0.00%0.0%
Q3 2021$11,752,000
-7.8%
440,650
+6.5%
0.00%0.0%
Q2 2021$12,740,000
+0.2%
413,763
-14.8%
0.00%0.0%
Q1 2021$12,715,000
-4.8%
485,679
-8.5%
0.00%0.0%
Q4 2020$13,358,000
+10.2%
530,928
-8.8%
0.00%0.0%
Q3 2020$12,127,000
-19.6%
581,894
-8.4%
0.00%
-25.0%
Q2 2020$15,084,000
+20.0%
635,120
-9.1%
0.00%0.0%
Q1 2020$12,567,000
-24.2%
698,5470.0%0.00%
-20.0%
Q4 2019$16,570,000
-13.7%
698,5470.0%0.01%
-16.7%
Q3 2019$19,196,000
-20.5%
698,547
-4.3%
0.01%
-14.3%
Q2 2019$24,150,000
-5.6%
729,8450.0%0.01%
-12.5%
Q1 2019$25,573,000
+3.5%
729,845
-1.9%
0.01%
-11.1%
Q4 2018$24,711,000
-34.0%
743,8450.0%0.01%
-25.0%
Q3 2018$37,453,000
-15.9%
743,8450.0%0.01%
-20.0%
Q2 2018$44,519,000
+46.7%
743,845
+12.3%
0.02%
+36.4%
Q1 2018$30,338,000
+29.8%
662,409
+12.9%
0.01%
+37.5%
Q4 2017$23,376,000
+45.7%
586,591
+46.2%
0.01%
+33.3%
Q3 2017$16,048,000401,1930.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders